2021年12月22日简报:上海和哈尔滨重回低风险区,西安本轮疫情已进入病例报告高峰期;奥密克戎全面占领欧美国家,已见少量死亡病例

2021-12-22 MedSci整理 MedSci整理

截至北京时间2021年12月22日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿7654万例,新增729,535例,达到276,541,

截至北京时间2021年12月22日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过2亿7654万例,新增729,535例,达到276,541,395例。累计死亡病例538.4万例,达到5,384,336例。新增死亡为6,846例。康复为247,991,448例,重症和危重症病人达到89,137例;全球新冠确诊病例超过100万例的国家达42个,113个国家病例超10万例。昨日报道:2021年12月21日简报:奥密克戎已成美国第一大感染源,奥密克戎加速替代Delta,新冠疫苗接种者、康复者均可能感染或再次感染奥密克戎

 

世卫组织:已有106个国家和地区出现奥密克戎毒株

当地时间21日,世卫组织发布新冠肺炎每周流行病学报告。报告指出,当前全球主要流行毒株仍为新冠变异病毒德尔塔毒株。在各国搜集的1051598份病毒基因序列样本中,96%的样本为德尔塔毒株,奥密克戎毒株约占1.6%,但一些国家已出现奥密克戎毒株社区传播。

世卫组织表示,截至欧洲中部时间12月21日14时,全球已有106个国家和地区出现奥密克戎毒株。近期证据表明,奥密克戎毒株比德尔塔毒株更有传播优势,且正在迅速传播,因此该毒株的整体风险仍为非常高。

美国新增超22万例确诊病例 现首例奥密克戎变异株死亡病例,生前未打疫苗

根据Worldometer实时统计数据,截至北京时间12月22日6时30分左右,美国累计确诊新冠肺炎病例52157610例,累计死亡病例830309例。与前一日6时30分数据相比,美国新增确诊病例224634例,新增死亡病例2409例。

综合《今日美国》《华尔街日报》等美媒20日报道,美国疾控中心(CDC)表示,奥密克戎毒株感染者占美国新增病例的73%,一周内增加近6倍。美国卫生官员20日表示,奥密克戎现在已成为美国流行的主要毒株。

当地时间20日,美国报告首例因感染新冠病毒奥密克戎毒株死亡病例,患者来自得克萨斯州哈里斯县。

当地卫生部门在一份声明中表示,这名患者年龄在50岁至60岁之间,生前没有接种新冠疫苗。声明强调,没有接种疫苗意味着出现并发症的风险更高,当地一名官员在社交媒体上呼吁民众尽快接种。

近段时间以来,奥密克戎毒株在美国迅速扩散,当地时间20日,美国疾病控制与预防中心(CDC)公布的数据显示,最近一周,全美新增病例的73%都由该变种引起。

萧华:NBA目前出现的90%阳性病例都是奥密克戎

今日NBA总裁亚当-萧华做客直播节目《NBA Today》谈到了联盟目前情况。

萧华透露,NBA目前出现的90%阳性病例都是变异毒株奥密克戎所致,而且据联盟数据统计,加强针是非常有效的,接受加强针的球员要么没有症状,要么症状非常轻微。

英国奥密克戎毒株感染病例超6万例

英国卫生安全局21日公布的最新数据显示,过去24小时英国新增新冠变异病毒奥密克戎毒株感染病例15363例,累计上升至60508例。多地采取进一步措施以遏制奥密克戎毒株的传播。

伦敦市长萨迪克·汗宣布取消计划在特拉法加广场举行的有6500人参加的大型跨年庆祝活动。他说,届时将有一场电视直播庆祝新年,希望人们在家中观看。

苏格兰地区宣布从12月26日起实行为期3周的新防疫措施,具体包括所有户外活动必须在500人以下,室内活动如音乐会最多只能有200名观众等。

当天,英国财政大臣苏纳克宣布设立一项10亿英镑的基金,来帮助因新冠肺炎确诊病例数上升而受到打击的企业。

据英国卫生部12月21日公布的最新数据,过去24小时英国新增新冠肺炎确诊病例90629例,累计确诊11542143例;新增死亡病例172例,累计死亡病例147433例。

英格兰报告累计14例奥密克戎毒株死亡病例

英国卫生安全局20日报告本国新增奥密克戎毒株感染病例8044例,累计45145例;英格兰已报告14例奥密克戎毒株死亡病例。

英国政府20日公布的数据显示,该国新增新冠确诊病例91743例,累计确诊超过1145万例;新增死亡病例44例,累计死亡147261例。

德国新增超2.3万例确诊 预计奥密克戎毒株将成为德国主要感染毒株

根据德国联邦疾控机构罗伯特·科赫研究所发布的最新数据,截至当地时间12月21日0时,德国累计新冠肺炎确诊病例6833050例,较前一日新增23428例;累计死亡108814例,较前一日新增462例。

当地时间21日,德国常设疫苗接种委员会宣布,鉴于对新冠变异病毒奥密克戎毒株传播的担忧,该委员会正式建议将第二针疫苗接种和疫苗加强针接种的间隔时间由之前的6个月缩短为3个月,该建议适用于所有成年人。该委员会还表示,预计奥密克戎毒株将在“很短的时间内”成为德国的主要感染毒株,而进行疫苗加强针接种能够有效地防止重症和降低感染传播的风险。常设疫苗接种委员会呼吁为老年人和高危人群优先接种疫苗加强针。

以色列奥密克戎毒株感染病例上升至341例

当地时间21日下午,以色列卫生部发布消息,称该国新冠变异病毒奥密克戎毒株感染病例已上升至341例。这与以卫生部上一次在19日公布的175例确诊病例相比,数量几乎增加了一倍。

以色列卫生部指出,在341例确诊病例中,有234例为从南非、英国等国入境以色列的人员,有29例为入境人员密切接触者,有66例在当地社区感染,另有12例尚未查明。与此同时,在全部341例确诊病例中,有246例接种过至少两剂新冠疫苗。除此以外,该国目前还有807例疑似奥密克戎毒株感染病例。

丹麦卫生部长:奥密克戎毒株已成丹麦主导毒株

当地时间21日,丹麦卫生大臣马格努斯·霍伊尼克通过社交媒体表示,丹麦国家血清研究所称,奥密克戎毒株已成丹麦主导的新冠变异毒株,且奥密克戎毒株感染率仍在增长。

丹麦21日新增新冠肺炎确诊病例达到13558例,创下单日新增确诊病例数纪录。

陕西西安今起将开展新一轮全员核酸检测

西安市疫情防控指挥部办公室下发通知,12月9日以来,西安市出现了多例新冠肺炎病例。为了快速、精准发现潜在传染源,彻底阻断疫情,经市疫情防控指挥部研究决定,在前期全市开展大规模核酸检测的基础上,自12月21日起启动新一轮全员核酸检测工作。

哈尔滨市全域均调整为低风险地区

根据国务院联防联控机制有关规定,经专家咨询组综合评估研判,哈尔滨市指挥部决定,自2021年12月22日3时30分起,将道里区民安小区(6栋、7栋围合区域)调整为低风险地区。调整后,哈尔滨市全域均为低风险地区。

“上海造”新冠疫苗获批上市

国药集团中国生物上海生物制品研究所分包装生产的首批新冠疫苗“众爱可维”今日正式获批上市。新建分包装车间用于生产新冠疫苗的有2条西林瓶分装线和4条西林瓶包装线,每分钟可灌装500剂疫苗,年产能预计2亿剂次。

西安本轮疫情已进入病例报告高峰期

此轮疫情,西安市出现隐匿性传播,形成一定规模的社区传播,现已出现外溢病例,波及咸阳、延安和东莞、北京。经专家研判,西安本轮疫情已经进入病例报告高峰期。

陕西省卫生健康委员会党组成员、省疾控中心主任刘峰介绍,自12月9日以来,全省累计报告本土确诊病例96例(西安市91例、延安市3例、咸阳市2例)。截至12月21日12时,全省累计排查管控密接者7620人、次密接者17452人。目前西安市划定高风险地区1个、中风险地区13个。

截至目前,陕西省疾控中心共对36例本土病例标本进行了全基因组测序,全部为德尔塔变异株,均与12月4日巴基斯坦入境航班PK854旅客中发现的境外输入病例高度同源。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1772141, encodeId=670d1e7214198, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Fri Jun 10 22:10:03 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010963, encodeId=72722010963a6, content=<a href='/topic/show?id=7a9d398883b' target=_blank style='color:#2F92EE;'>#哈尔滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39888, encryptionId=7a9d398883b, topicName=哈尔滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Sun Apr 03 01:10:03 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187788, encodeId=3e50118e78804, content=非常受益!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Jan 24 19:35:30 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084436, encodeId=39eb108443689, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84525501709, createdName=ms1000000615957901, createdTime=Sun Dec 26 17:45:58 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377052, encodeId=b52313e70526e, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Thu Dec 23 23:10:03 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082972, encodeId=047610829e286, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b46c5161688, createdName=张三123, createdTime=Wed Dec 22 09:35:48 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1772141, encodeId=670d1e7214198, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Fri Jun 10 22:10:03 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010963, encodeId=72722010963a6, content=<a href='/topic/show?id=7a9d398883b' target=_blank style='color:#2F92EE;'>#哈尔滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39888, encryptionId=7a9d398883b, topicName=哈尔滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Sun Apr 03 01:10:03 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187788, encodeId=3e50118e78804, content=非常受益!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Jan 24 19:35:30 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084436, encodeId=39eb108443689, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84525501709, createdName=ms1000000615957901, createdTime=Sun Dec 26 17:45:58 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377052, encodeId=b52313e70526e, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Thu Dec 23 23:10:03 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082972, encodeId=047610829e286, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b46c5161688, createdName=张三123, createdTime=Wed Dec 22 09:35:48 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-04-03 sunyl07
  3. [GetPortalCommentsPageByObjectIdResponse(id=1772141, encodeId=670d1e7214198, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Fri Jun 10 22:10:03 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010963, encodeId=72722010963a6, content=<a href='/topic/show?id=7a9d398883b' target=_blank style='color:#2F92EE;'>#哈尔滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39888, encryptionId=7a9d398883b, topicName=哈尔滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Sun Apr 03 01:10:03 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187788, encodeId=3e50118e78804, content=非常受益!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Jan 24 19:35:30 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084436, encodeId=39eb108443689, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84525501709, createdName=ms1000000615957901, createdTime=Sun Dec 26 17:45:58 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377052, encodeId=b52313e70526e, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Thu Dec 23 23:10:03 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082972, encodeId=047610829e286, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b46c5161688, createdName=张三123, createdTime=Wed Dec 22 09:35:48 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-01-24 妙医生

    非常受益!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1772141, encodeId=670d1e7214198, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Fri Jun 10 22:10:03 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010963, encodeId=72722010963a6, content=<a href='/topic/show?id=7a9d398883b' target=_blank style='color:#2F92EE;'>#哈尔滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39888, encryptionId=7a9d398883b, topicName=哈尔滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Sun Apr 03 01:10:03 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187788, encodeId=3e50118e78804, content=非常受益!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Jan 24 19:35:30 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084436, encodeId=39eb108443689, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84525501709, createdName=ms1000000615957901, createdTime=Sun Dec 26 17:45:58 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377052, encodeId=b52313e70526e, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Thu Dec 23 23:10:03 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082972, encodeId=047610829e286, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b46c5161688, createdName=张三123, createdTime=Wed Dec 22 09:35:48 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1772141, encodeId=670d1e7214198, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Fri Jun 10 22:10:03 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010963, encodeId=72722010963a6, content=<a href='/topic/show?id=7a9d398883b' target=_blank style='color:#2F92EE;'>#哈尔滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39888, encryptionId=7a9d398883b, topicName=哈尔滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Sun Apr 03 01:10:03 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187788, encodeId=3e50118e78804, content=非常受益!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Jan 24 19:35:30 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084436, encodeId=39eb108443689, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84525501709, createdName=ms1000000615957901, createdTime=Sun Dec 26 17:45:58 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377052, encodeId=b52313e70526e, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Thu Dec 23 23:10:03 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082972, encodeId=047610829e286, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b46c5161688, createdName=张三123, createdTime=Wed Dec 22 09:35:48 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1772141, encodeId=670d1e7214198, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Fri Jun 10 22:10:03 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010963, encodeId=72722010963a6, content=<a href='/topic/show?id=7a9d398883b' target=_blank style='color:#2F92EE;'>#哈尔滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39888, encryptionId=7a9d398883b, topicName=哈尔滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Sun Apr 03 01:10:03 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187788, encodeId=3e50118e78804, content=非常受益!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a18cf35bdfab43d496bab2a120649fae/3b4d7ff9e9364c3bae15229ee94a1b36.jpg, createdBy=9ea25397643, createdName=妙医生, createdTime=Mon Jan 24 19:35:30 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084436, encodeId=39eb108443689, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84525501709, createdName=ms1000000615957901, createdTime=Sun Dec 26 17:45:58 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377052, encodeId=b52313e70526e, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Thu Dec 23 23:10:03 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082972, encodeId=047610829e286, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b46c5161688, createdName=张三123, createdTime=Wed Dec 22 09:35:48 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 张三123

    谢谢

    0

相关资讯

2021年11月10日简报:英美全面开放国际旅行,中国疫苗被认可;法国要求65岁以上老人接种第三剂新冠疫苗;以色列打加强针后,疫情再度得到控制

截至北京时间2021年11月10日8时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5149万例,新增420,552例,达到251,494,

2021年11月17日简报:新冠疫情对心理健康的影响或将持续多年;国内老年人新冠疫苗接种率仍需大幅提高;辉瑞新冠口服药允许95个国家仿制

截至北京时间2021年11月17日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5503万例,新增465,781例,达到255,036,

北京本轮疫情已波及三区,严格出京审批!什么方法可以遏制新冠的传播吗?

秋冬季节的到来可能使得新冠病毒在环境中存活的时间变长,加大了传染风险。仅仅7天,本轮疫情已波及陕西、宁夏、内蒙古、北京等11省区市,而北京本轮疫情已波及昌平区、丰台区、海淀区三区。

2021年10月24日简报:新一波全球疫情开始抬头,第三新冠的冬天可能并不平坦;新的变异病毒品种为“AY.4.2”,可能会引发广泛流行

截至北京时间2021年10月24日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4408万例,新增371,400例,达到244,085,